首页|肺结核合并肺癌患者的危险因素及耐药情况分析

肺结核合并肺癌患者的危险因素及耐药情况分析

扫码查看
采用病例对照研究方法,选取 2017 年 5 月至 2021 年 5 月在莆田学院附属医院同期治疗的肺结核合并肺癌患者 77 例以及单纯肺结核患者 86 例,进行临床资料分析,探索其危险因素及结核分枝杆菌耐药情况,以便早期识别.研究结果表明,肺结核患者有并发肺癌的风险,两者合并时有一定的临床特征和影像学特点,同时获得性耐药率及耐多药比率明显增加,应尽早识别危险因素、早期诊断并同时治疗,以便获得更好的疗效.
Analysis of Risk Factors and Drug Resistance in Patients with Pulmonary Tuberculosis and Lung Cancer
77 patients with pulmonary tuberculosis combined with lung cancer and 86 patients with simple pulmonary tuberculosis treated in our hospital during the same period from May 2017 to May 2021 were selected for clinical data analyses by using the case-control study method,and their risk factors and drug resistance of mycobacterium tuberculosis were explored for early identification.The results show that pulmonary tuberculosis patients are at risk of lung cancer,which has certain clinical and imaging characteristics.The rate of simultaneous acquired drug resistance and multidrug resistance increased significantly.Risk factors should be identified as early as possible,and early diagnosis and simultaneous treatment should be performed to obtain better curative effect.

tuberculosislung cancerrisk factorsmycobacterium tuberculosisdrug resistance

朱林剑、许勇飞、陈渟桑、林丹

展开 >

莆田学院附属医院 结核科,福建 莆田 351100

肺结核 肺癌 危险因素 结核分枝杆菌 耐药性

2024

莆田学院学报
莆田学院

莆田学院学报

影响因子:0.239
ISSN:1672-4143
年,卷(期):2024.31(5)